Robot-assisted Pyeloplasty with HUGOTM Robotic System: Initial Experience and Optimal Surgical Set-up at a Tertiary Referral Robotic Center.


Journal

Journal of endourology
ISSN: 1557-900X
Titre abrégé: J Endourol
Pays: United States
ID NLM: 8807503

Informations de publication

Date de publication:
25 Jan 2024
Historique:
medline: 25 1 2024
pubmed: 25 1 2024
entrez: 25 1 2024
Statut: aheadofprint

Résumé

In February 2021 Medtronic® (Minneapolis, MN) launched the HUGOTM Robotic Assisted Surgery (RAS) System in the global market. The aim of the current study is to describe the first cases series and the optimal setup of robot-assisted pyeloplasty procedure, performed with HUGOTM RAS system in a tertiary referral robotic center. Data from consecutive patients who underwent robot-assisted pyeloplasty at OLV Hospital (Aalst, Belgium) were recorded. Baseline characteristics, perioperative and surgical outcomes were collected. Overall, ten robot-assisted pyeloplasties were performed (October 2022-September 2023). Based on our expertise, the following minor setting changes have been made, relative to the official setup guide: the endoscope port and, subsequently, the left and right-hand ports were positioned more laterally. Additionally, the reserve/4th port was placed more laterally and cranially, and adjusted the arm cart's tilt angle, reducing it from -30° to -15°. The median docking time was 8 (Interquartile range [IQR]: 7.2-9.8) minutes, and the median active console time was 89.5 (80.0-95.8) minutes. No conversion to open/laparoscopic surgery or perioperative complications were encountered. A single technical problem was recorded in one (10%) procedure. Specifically, one arm was blocked, and the procedure was accomplished with three arms without compromising the procedure success. This study represents the first worldwide series of robot-assisted pyeloplasty performed with the HUGOTM RAS system and shows promising results. The procedure might be safely performed with this robotic platform achieving optimal perioperative outcomes.

Sections du résumé

BACKGROUND BACKGROUND
In February 2021 Medtronic® (Minneapolis, MN) launched the HUGOTM Robotic Assisted Surgery (RAS) System in the global market. The aim of the current study is to describe the first cases series and the optimal setup of robot-assisted pyeloplasty procedure, performed with HUGOTM RAS system in a tertiary referral robotic center.
METHODS METHODS
Data from consecutive patients who underwent robot-assisted pyeloplasty at OLV Hospital (Aalst, Belgium) were recorded. Baseline characteristics, perioperative and surgical outcomes were collected.
RESULTS RESULTS
Overall, ten robot-assisted pyeloplasties were performed (October 2022-September 2023). Based on our expertise, the following minor setting changes have been made, relative to the official setup guide: the endoscope port and, subsequently, the left and right-hand ports were positioned more laterally. Additionally, the reserve/4th port was placed more laterally and cranially, and adjusted the arm cart's tilt angle, reducing it from -30° to -15°. The median docking time was 8 (Interquartile range [IQR]: 7.2-9.8) minutes, and the median active console time was 89.5 (80.0-95.8) minutes. No conversion to open/laparoscopic surgery or perioperative complications were encountered. A single technical problem was recorded in one (10%) procedure. Specifically, one arm was blocked, and the procedure was accomplished with three arms without compromising the procedure success.
CONCLUSIONS CONCLUSIONS
This study represents the first worldwide series of robot-assisted pyeloplasty performed with the HUGOTM RAS system and shows promising results. The procedure might be safely performed with this robotic platform achieving optimal perioperative outcomes.

Identifiants

pubmed: 38269425
doi: 10.1089/end.2023.0598
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Silvia Rebuffo (S)

IRCCS Ospedale Policlinico San Martino, 9246, Department of Urology, Genova, Liguria, Italy; silvia.rebuffo@gmail.com.

Marco Ticonosco (M)

University of Modena and Reggio Emilia, 9306, Urology, Modena, Emilia-Romagna, Italy; marco.ti151992@gmail.com.

Claudia Collà Ruvolo (C)

University of Naples Federico II School of Medicine and Surgery, 478484, Department of Urology, via pansini 5, Napoli, Italy, 80131; c.collaruvolo@gmail.com.

Alessandro Pissavini (A)

IRCCS University Hospital of Bologna Sant Orsola Polyclinic, 18508, Department of Urology, Bologna, Emilia-Romagna, Italy; alessandro.pissavini@gmail.com.

Eleonora Balestrazzi (E)

IRCCS Azienda Ospedaliero-Universitaria di Bologna, 18508, Department of Urology, Bologna, Emilia-Romagna, Italy; eleonora.balestrazzi@gmail.com.

Marco Paciotti (M)

IRCCS Humanitas Research Hospital, 9268, Department of Urology, Rozzano, Lombardia, Italy; paciottimarco@gmail.com.

Nicola Frego (N)

IRCCS Humanitas Research Hospital, 9268, Department of Urology, Rozzano, Lombardia, Italy; nicola.frego@gmail.com.

Gabriele Sorce (G)

IRCCS Ospedale San Raffaele, 9372, Unit of Urology, Division of Experimental Oncology, Urological Research Institute, Milano, Lombardia, Italy; gab.sorce@gmail.com.

Mario Belmonte (M)

University Hospital Careggi, 18561, Department of Urology, Firenze, Toscana, Italy; mario.belmonte@unifi.it.

Maria Peraire (M)

Onze-Lieve-Vrouwziekenhuis, 37467, Aalst, Oost-Vlaanderen, Belgium; mperairelores@gmail.com.

Adele Piro (A)

Università degli Studi di Modena e Reggio Emilia, 9306, Department of Urology, University of Modena and Reggio Emilia, Largo del Pozzo, 71, 41125 Modena MO, Italia, Modena, Italy, 41121; piro.adele18@gmail.com.

Federico Piramide (F)

San Luigi Gonzaga University Hospital, 9340, Department of Urology, Orbassano, Piemonte, Italy; federico.piramide@gmail.com.

Carlo Bravi (C)

The Royal Marsden, 158993, Department of Urology, London, London, United Kingdom of Great Britain and Northern Ireland.
Onze-Lieve-Vrouwziekenhuis, 37467, Aalst, Oost-Vlaanderen, Belgium.
IRCCS Ospedale San Raffaele, 9372, Milano, Lombardia, Italy.
Vita-Salute San Raffaele University, 18985, Milano, Lombardia, Italy; carloandrea.bravi@gmail.com.

Ruben De Groote (R)

OLV Ziekenhuis Campus Aalst, 74840, Urology, Aalst, Oost-Vlaanderen, Belgium; degroote.ruben@gmail.com.

Alexandre Mottrie (A)

Onze Lieve Vrouwziekenhuis, 37467, Dep. of Urology, Aalst, Belgium, 9300; a.mottrie@gmail.com.

Geert Naeyer (G)

Onze Lieve Vrouwziekenhuis, 37467, Dep. of Urology, moorselbaan, 164, Aalst, Belgium, 9300; geert.de.naeyer@olvz-aalst.be.

Classifications MeSH